Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Sotero Elias Peralta, MD, is a vascular surgeon in the Department of Vascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute. He is board certified in surgery and vascular surgery. Dr. Peralta has been an associate staff member since 2011 and was appointed to the Cleveland Clinic staff in 2013.
Dr. Peralta received his medical degree from the Universidad Nacional Pedro Henriquez Urena, Santo Domingo, Dominican Republic, graduating magna cum laude with the highest grade point average in his class. After completing a one-year postdoctoral program at the Unversidad Central del Caribe Hospital, Bayamone, Puerto Rico, he served a general surgery residency at Monmouth Medical Center, Long Branch, N.J.
As a resident, Dr. Peralta received numerous awards for academic excellence, teaching medical students and residents and overall achievement, including the Monmouth Medical Center John C. Borden Award for outstanding service in the field of general surgery. He completed his postdoctoral training as a vascular surgery fellow at North Shore-Long Island Jewish Health System, Great Neck, N.Y.
Dr. Peralta has published a number of papers on aneurysm repair and other specialized vascular surgeries and presented at national vascular conferences.
In addition to English, he is fluent in Spanish.
Aortic aneurysms, carotid artery disease, cerebrovascular disease, peripheral artery disease, aorta surgery, carotid endarterectomy, carotid stenting, dialysis access procedures, surgery for peripheral arterial disease (PAD), aortic aneurysm open repair and endovascular repair
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/24/2015, Dr. Peralta has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.